Nasdaq3d
Biodexa Pharmaceuticals Receives FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Treatment
with current standard care being surgical removal of the colon and rectum. The Phase 2 study of eRapa showed promising results, including a median 17% reduction in polyp burden and a 75% non ...
Monthly Prescribing Reference2d
Encapsulated Rapamycin Fast Tracked for Familial Adenomatous Polyposis
The Fast Track designation is supported by data from a phase 2 trial that evaluated eRapa in 30 adult patients with FAP.
Yahoo Finance3d
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
Data from the Phase 2 study of eRapa in FAP showed eRapa to be safe and well-tolerated with a median 17% reduction in total polyp burden at 12 months compared with baseline and an overall 75% non ...
Medscape6d
Relationship of Non-alcoholic Fatty Liver Disease to Colorectal Adenomatous Polyps
This investigation was initiated to determine whether NAFLD has a relationship to colorectal adenomatous polyps. Results: The prevalence of NAFLD was 41.5% in the adenomatous polyp group and 30.2% ...
ZDNet6d
The best services for deleting yourself from the internet
Amassing many positive customer reviews, Surfshark's Incogni tackles data removal and data brokers on your behalf and will enforce these requests using applicable data protection laws. You pay the ...
gut.bmj5d
Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes
Flat adenomas frequently contain severely dysplastic tissue, and may progress rapidly through the adenoma-carcinoma sequence ... underwent screening by flexible sigmoidoscopy. Methods—All polyps were ...